Paraneoplastic Neurologic Disorders
Open Access
- 1 January 2004
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 61 (1) , 30-32
- https://doi.org/10.1001/archneur.61.1.30
Abstract
Neurologists have been fascinated by the paraneoplastic neurologic disorders (PNDs) for over a century. In the past 20 years, PNDs have emerged as prime examples of the way in which modern molecular biology can be used to transform esoteric medicine into widely applicable scientific and clinical insights.Keywords
This publication has 12 references indexed in Scilit:
- CLIP Identifies Nova-Regulated RNA Networks in the BrainScience, 2003
- Observing the invisible: successful tumor immunity in humansNature Immunology, 2003
- The splice of life: Alternative splicing and neurological diseaseNature Reviews Neuroscience, 2001
- Nova-1 Regulates Neuron-Specific Alternative Splicing and Is Essential for Neuronal ViabilityNeuron, 2000
- Sequence-Specific RNA Binding by a Nova KH DomainCell, 2000
- Tumor-specific killer cells in paraneoplastic cerebellar degenerationNature Medicine, 1998
- The Neuronal RNA Binding Protein Nova-1 Recognizes Specific RNA Targets In Vitro and In VivoMolecular and Cellular Biology, 1997
- Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.Proceedings of the National Academy of Sciences, 1996
- Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes.The Journal of Experimental Medicine, 1994
- Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor systemNeuron, 1993